CoChat

The DOI matches its Crossref record; 191 of the 193 references it cites were found in a registry or an index.

Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy

Open access

Abstract

Idiopathic inflammatory myopathies (IIMs), which are a group of chronic and diverse inflammatory diseases, are primarily characterized by weakness in the proximal muscles that progressively leads to persistent disability. Current treatments of IIMs depend on nonspecific immunosuppressive agents (including glucocorticoids and immunosuppressants). However, these therapies sometimes fail to regulate muscle inflammation, and some patients suffer from infectious diseases and other adverse effects related to the treatment. Furthermore, even after inflammation has subsided, muscle weakness persists in a significant proportion of the patients. Therefore, the elucidation of pathophysiology of IIMs and development of a better therapeutic strategy that not only alleviates muscle inflammation but also improves muscle weakness without increment of opportunistic infection is awaited. Muscle fiber death, which has been formerly postulated as “necrosis”, is a key histological feature of all subtypes of IIMs, however, its detailed mechanisms and contribution to the pathophysiology remained to be elucidated. Recent studies have revealed that muscle fibers of IIMs undergo necroptosis, a newly recognized form of regulated cell death, and promote muscle inflammation and dysfunction through releasing inflammatory mediators such as damage-associated molecular patterns (DAMPs). The research on murine model of polymyositis, a subtype of IIM, revealed that the inhibition of necroptosis or HMGB1, one of major DAMPs released from muscle fibers undergoing necroptosis, ameliorated muscle inflammation and recovered muscle weakness. Furthermore, not only the necroptosis-associated molecules but also PGAM5, a mitochondrial protein, and reactive oxygen species have been shown to be involved in muscle fiber necroptosis, indicating the multiple target candidates for the treatment of IIMs acting through necroptosis regulation. This article overviews the research on muscle injury mechanisms in IIMs focusing on the contribution of necroptosis in their pathophysiology and discusses the potential treatment strategy targeting muscle fiber necroptosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fimmu.2023.1191815

Cites

191 of 191 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Contribution of muscle fiber necroptosis to pathophysiology of PM. In PM patients, following the injury by CTLs, muscle fibers undergo FAS-mediated necroptosis. During necroptosis, intracellular contents, including DAMPs such as HMGB1, are released to extracellular space. Through binding to PRRs such as TLR4, HMGB1 activates myeloid linage cells including macrophages and dendritic cells, enhancing their antigen presentation and inflammatory cytokine production. These innate inflammatory responses thereby contribute to the activation of the acquired immunity including autoreactive T cell activation and further muscle injury. PRRs are also upregulated in the muscle fibers of PM, and HMGB1 induces ER stress, upregulation of MHC class I, and muscle dysfunction. To summarize, through both inflammatory and non-inflammatory effects, necroptosis in muscle fibers contributes to the pathophysiology of PM. CTL, cytotoxic T cell; DAMPs, damage-associated molecular patterns; PRRs, pattern-recognition receptors; ER, endoplasmic reticulum; MHC, Major Histocompatibility Complex.
Figure 1 Contribution of muscle fiber necroptosis to pathophysiology of PM. In PM patients, following the injury by CTLs, muscle fibers undergo FAS-mediated necroptosis. During necroptosis, intracellular contents, including DAMPs such as HMGB1, are released to extracellular space. Through binding to PRRs such as TLR4, HMGB1 activates myeloid linage cells including macrophages and dendritic cells, enhancing their antigen presentation and inflammatory cytokine production. These innate inflammatory responses thereby contribute to the activation of the acquired immunity including autoreactive T cell activation and further muscle injury. PRRs are also upregulated in the muscle fibers of PM, and HMGB1 induces ER stress, upregulation of MHC class I, and muscle dysfunction. To summarize, through both inflammatory and non-inflammatory effects, necroptosis in muscle fibers contributes to the pathophysiology of PM. CTL, cytotoxic T cell; DAMPs, damage-associated molecular patterns; PRRs, pattern-recognition receptors; ER, endoplasmic reticulum; MHC, Major Histocompatibility Complex.CC BY · PubMed Central
Figure 2 Mechanisms controlling muscle fiber necroptosis in PM and effect of GLP-1R agonist on inhibiting muscle fiber necroptosis. In PMs, PGAM5 and ROS contribute to necroptosis in muscle fibers, along with necroptosis-associated molecules such as RIPI1, RIPK3 and MLKL. PGAM5 is upregulated in necroptotic muscle fibers and serves as a convergence point for necroptosis execution. ROS accumulation during necroptosis further enhances the necroptotic process through promoting necrosome formation. A GLP-1R agonist suppresses the expression of PGAM5 in AMPK dependent manner. Furthermore, the GLP-1R agonist upregulates antioxidant molecules such as NFE2L2, HMOX1, GCLM, and NQO1 in muscle fibers, suppressing ROS accumulation. By targeting PGAM5 and ROS, the GLP-1R agonist inhibits muscle fiber necroptosis, thereby ameliorating PM models. ROS, reactive oxygen species; pAMPKα, phosphorylated AMP-activated protein kinase α; DAMPs, damage-associated molecular patterns; Nec1s, necrostatin-1s. P stands for phosphorylated form.
Figure 2 Mechanisms controlling muscle fiber necroptosis in PM and effect of GLP-1R agonist on inhibiting muscle fiber necroptosis. In PMs, PGAM5 and ROS contribute to necroptosis in muscle fibers, along with necroptosis-associated molecules such as RIPI1, RIPK3 and MLKL. PGAM5 is upregulated in necroptotic muscle fibers and serves as a convergence point for necroptosis execution. ROS accumulation during necroptosis further enhances the necroptotic process through promoting necrosome formation. A GLP-1R agonist suppresses the expression of PGAM5 in AMPK dependent manner. Furthermore, the GLP-1R agonist upregulates antioxidant molecules such as NFE2L2, HMOX1, GCLM, and NQO1 in muscle fibers, suppressing ROS accumulation. By targeting PGAM5 and ROS, the GLP-1R agonist inhibits muscle fiber necroptosis, thereby ameliorating PM models. ROS, reactive oxygen species; pAMPKα, phosphorylated AMP-activated protein kinase α; DAMPs, damage-associated molecular patterns; Nec1s, necrostatin-1s. P stands for phosphorylated form.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 191 references

Cited by

See all 21

Metadata

Authors
Kamiya, M., Kimura, N., Umezawa, N., Hasegawa, H., & Yasuda, S.
Affiliations
Tokyo Medical and Dental University (JP)
Corresponding author
Yasuda, Shinsuke
Venue
Frontiers in Immunology
Published
2023-07-07
Volume
14
Pages
1191815-1191815
ISSN
1664-3224 (ISSN-L)
OpenAlex
W4383534034
Cited by
21
References
193
Citations by year
2026: 8 · 2025: 8 · 2024: 5
FWCI
0.82
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Immunology (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Rheumatology › Inflammatory Myopathies and Dermatomyositis
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Keywords
idiopathic inflammatory myopathies, polymyositis, HMGB1, damage-associated molecular patterns, PGAM5, reactive oxygen species, muscle inflammation, muscle weakness, regulated cell death, therapeutic target
MeSH terms
Necroptosis, Animals, Humans, Inflammation, Myositis, Muscle Fibers, Skeletal, Muscle Weakness, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy. https://app.cochat.ai/papers/10.3389/fimmu.2023.1191815
The paper
Kamiya, M., Kimura, N., Umezawa, N., Hasegawa, H., & Yasuda, S. (2023). Muscle fiber necroptosis in pathophysiology of idiopathic inflammatory myopathies and its potential as target of novel treatment strategy. Frontiers in Immunology. https://doi.org/10.3389/fimmu.2023.1191815

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.